(XLG) SP500 Top 50 - Overview
Etf: Technology, Healthcare, Financials, Consumer, Communication
Dividends
| Dividend Yield | 0.70% |
| Yield on Cost 5y | 1.34% |
| Yield CAGR 5y | -42.42% |
| Payout Consistency | 97.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.9% |
| Relative Tail Risk | 5.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.57 |
| Alpha | -0.72 |
| Character TTM | |
|---|---|
| Beta | 1.036 |
| Beta Downside | 1.027 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.70% |
| CAGR/Max DD | 1.27 |
Description: XLG SP500 Top 50 January 06, 2026
The Invesco S&P 500® Top 50 ETF (XLG) seeks to track an index that holds the 50 largest S&P 500 constituents by float-adjusted market cap, allocating at least 90% of assets to those securities. The index is market-cap weighted and the fund is classified as a non-diversified large-blend ETF.
Key metrics as of the most recent filing: an expense ratio of 0.10%, an average daily trading volume of roughly 300,000 shares, and a 12-month return that closely mirrors the top-50 segment of the S&P 500 (≈ +9%). The fund’s sector tilt leans heavily toward Information Technology (≈ 35% of assets) and Health Care (≈ 15%), reflecting the concentration of mega-caps in those industries. A primary driver of performance is the overall health of the U.S. economy, particularly corporate earnings growth and monetary-policy outlook, which disproportionately affect large-cap stocks.
For a deeper dive into XLG’s risk-adjusted characteristics and how it fits into a broader portfolio, you might explore the analytics on ValueRay.
What is the price of XLG shares?
Over the past week, the price has changed by -1.64%, over one month by -1.64%, over three months by -2.10% and over the past year by +15.16%.
Is XLG a buy, sell or hold?
What are the forecasts/targets for the XLG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 70.5 | 20.9% |
XLG Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 11.42b USD (11.42b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 11.42b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 11.42b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.73% (E(11.42b)/V(11.42b) * Re(9.73%) + (debt-free company))
Discount Rate = 9.73% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)